US Stock MarketDetailed Quotes

HealthEquity (HQY)

Watchlist
  • 82.400
  • +0.370+0.45%
Close May 1 16:00 ET
  • 82.400
  • 0.0000.00%
Post 20:01 ET
6.96BMarket Cap33.50P/E (TTM)

HealthEquity (HQY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jan 31, 2026
(Q4)Jan 31, 2026
(Q3)Oct 31, 2025
(Q2)Jul 31, 2025
(Q1)Apr 30, 2025
(FY)Jan 31, 2025
(Q4)Jan 31, 2025
(Q3)Oct 31, 2024
(Q2)Jul 31, 2024
(Q1)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.50%457.09M
55.67%117.92M
53.04%138.58M
25.65%135.87M
-1.06%64.74M
39.96%339.86M
-1.72%75.75M
58.56%90.55M
40.23%108.13M
107.46%65.43M
Net income from continuing operations
122.54%215.2M
88.66%49.74M
806.40%51.69M
67.09%59.85M
87.12%53.92M
73.58%96.7M
0.00%26.37M
-61.13%5.7M
238.55%35.82M
603.79%28.81M
Operating gains losses
-101.02%-16K
----
----
----
----
36.21%1.58M
--0
----
----
----
Depreciation and amortization
-4.80%154.66M
-1.28%38.68M
-4.77%38.78M
-11.82%38.45M
-0.51%38.74M
6.12%162.45M
3.35%39.18M
7.78%40.72M
13.73%43.61M
-0.26%38.94M
Deferred tax
409.52%39.73M
-8.41%-3M
347.34%12.02M
15,871.20%29.39M
124.57%1.32M
8.28%-12.84M
-243.35%-2.77M
37.60%-4.86M
102.49%184K
-630.08%-5.39M
Other non cash items
-47.85%1.08M
4.58%274K
-28.12%271K
-63.03%268K
-62.30%265K
-27.52%2.07M
-62.68%262K
-45.28%377K
6.77%725K
-10.10%703K
Change In working capital
-307.64%-26.62M
245.83%13.12M
-41.08%15.27M
-279.67%-11.17M
-47.83%-43.84M
80.29%-6.53M
-27.65%-9M
361.57%25.91M
-58.09%6.21M
4.34%-29.66M
-Change in receivables
56.61%-5.69M
-10.26%-12.45M
-104.54%-79K
327.73%5.09M
232.08%1.75M
-62.73%-13.11M
-29.64%-11.29M
148.39%1.74M
-138.33%-2.24M
16.09%-1.33M
-Change in payables and accrued expense
-80.78%1.71M
181.78%12.98M
-8.77%27.55M
-1,266.07%-42.24M
245.80%3.42M
4,456.86%8.89M
-835.02%-15.87M
261.98%30.2M
70.98%-3.09M
-4,594.00%-2.35M
-Change in other current assets
-14.67%-5.88M
-7.88%-10.93M
103.58%22.36M
-76.91%-13.26M
-367.70%-4.05M
77.32%-5.13M
43.79%-10.13M
514.96%10.98M
-1,115.45%-7.49M
156.70%1.51M
-Change in other current liabilities
46.76%-7.95M
82.52%-751K
32.05%-1.48M
55.81%-2.97M
-57.98%-2.75M
-186.26%-14.94M
-1,584.71%-4.3M
-177.02%-2.18M
-3.90%-6.72M
-31.77%-1.74M
-Change in other working capital
-149.59%-8.81M
-24.31%15.83M
----
----
-63.88%-42.21M
501.76%17.76M
17.65%20.92M
----
----
-1.48%-25.76M
Cash from discontinued investing activities
Operating cash flow
34.50%457.09M
55.67%117.92M
53.04%138.58M
25.65%135.87M
-1.06%64.74M
39.96%339.86M
-1.72%75.75M
58.56%90.55M
40.23%108.13M
107.46%65.43M
Investing cash flow
Cash flow from continuing investing activities
90.67%-47.14M
37.77%-8.44M
11.54%-11.38M
94.65%-11.18M
94.02%-16.14M
-997.05%-505.45M
-20.29%-13.56M
16.57%-12.87M
-1,940.02%-209.08M
-2,855.12%-269.95M
Net PPE purchase and sale
5.52%-1.97M
0.61%-326K
-166.67%-784K
-4.32%-773K
88.07%-86K
-23.02%-2.08M
41.43%-328K
45.96%-294K
-61.79%-741K
-446.21%-721K
Net intangibles purchase and sale
90.70%-46.81M
26.32%-9.75M
15.70%-10.6M
95.00%-10.41M
94.04%-16.06M
-1,034.23%-503.37M
-23.52%-13.23M
15.49%-12.57M
-2,027.88%-208.34M
-2,890.44%-269.23M
Net investment purchase and sale
--1.64M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
90.67%-47.14M
37.77%-8.44M
11.54%-11.38M
94.65%-11.18M
94.02%-16.14M
-997.05%-505.45M
-20.29%-13.56M
16.57%-12.87M
-1,940.02%-209.08M
-2,855.12%-269.95M
Financing cash flow
Cash flow from continuing financing activities
-772.22%-386.98M
-12.90%-99.81M
-48.51%-122.4M
-161.22%-108.12M
-209.42%-56.65M
222.38%57.57M
-2,248.38%-88.41M
-4,163.86%-82.42M
8,295.68%176.62M
201.46%51.77M
Net issuance payments of debt
-157.14%-100M
0.00%-25M
0.00%-25M
-128.57%-50M
--0
421.84%175M
---25M
---25M
--175M
191.95%50M
Net common stock issuance
-146.31%-299.25M
-28.64%-81.02M
-57.95%-92.42M
---66.75M
---59.07M
---121.49M
---62.98M
---58.51M
--0
--0
Proceeds from stock option exercised by employees
21.04%11.41M
36.08%5.96M
-702.05%-5M
399.26%9.48M
-58.35%965K
45.70%9.43M
42.88%4.38M
-59.51%830K
333.56%1.9M
152.95%2.32M
Net other financing activities
116.15%867K
105.12%246K
-90.67%25K
-203.19%-855K
365.75%1.45M
-720.58%-5.37M
-558.78%-4.81M
1,318.18%268K
89.12%-282K
-122.45%-546K
Cash from discontinued financing activities
Financing cash flow
-772.22%-386.98M
-12.90%-99.81M
-48.51%-122.4M
-161.22%-108.12M
-209.42%-56.65M
222.38%57.57M
-2,248.38%-88.41M
-4,163.86%-82.42M
8,295.68%176.62M
201.46%51.77M
Net cash flow
Beginning cash position
-26.74%295.95M
-4.01%309.26M
-6.86%304.46M
14.59%287.89M
-26.74%295.95M
58.88%403.98M
-3.56%322.16M
12.59%326.89M
11.34%251.23M
58.88%403.98M
Current changes in cash
121.27%22.98M
136.88%9.67M
201.44%4.8M
-78.10%16.57M
94.73%-8.05M
-172.16%-108.03M
-137.49%-26.22M
-110.82%-4.73M
16.94%75.66M
-433.64%-152.75M
End cash Position
7.76%318.93M
7.76%318.93M
-4.01%309.26M
-6.86%304.46M
14.59%287.89M
-26.74%295.95M
-26.74%295.95M
-3.56%322.16M
12.59%326.89M
11.34%251.23M
Free cash flow
346.57%408.32M
73.40%107.84M
63.73%127.19M
223.51%124.69M
123.76%48.6M
-184.17%-165.6M
-5.49%62.19M
86.35%77.69M
-251.00%-100.95M
-1,012.92%-204.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jan 31, 2026(Q4)Jan 31, 2026(Q3)Oct 31, 2025(Q2)Jul 31, 2025(Q1)Apr 30, 2025(FY)Jan 31, 2025(Q4)Jan 31, 2025(Q3)Oct 31, 2024(Q2)Jul 31, 2024(Q1)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.50%457.09M55.67%117.92M53.04%138.58M25.65%135.87M-1.06%64.74M39.96%339.86M-1.72%75.75M58.56%90.55M40.23%108.13M107.46%65.43M
Net income from continuing operations 122.54%215.2M88.66%49.74M806.40%51.69M67.09%59.85M87.12%53.92M73.58%96.7M0.00%26.37M-61.13%5.7M238.55%35.82M603.79%28.81M
Operating gains losses -101.02%-16K----------------36.21%1.58M--0------------
Depreciation and amortization -4.80%154.66M-1.28%38.68M-4.77%38.78M-11.82%38.45M-0.51%38.74M6.12%162.45M3.35%39.18M7.78%40.72M13.73%43.61M-0.26%38.94M
Deferred tax 409.52%39.73M-8.41%-3M347.34%12.02M15,871.20%29.39M124.57%1.32M8.28%-12.84M-243.35%-2.77M37.60%-4.86M102.49%184K-630.08%-5.39M
Other non cash items -47.85%1.08M4.58%274K-28.12%271K-63.03%268K-62.30%265K-27.52%2.07M-62.68%262K-45.28%377K6.77%725K-10.10%703K
Change In working capital -307.64%-26.62M245.83%13.12M-41.08%15.27M-279.67%-11.17M-47.83%-43.84M80.29%-6.53M-27.65%-9M361.57%25.91M-58.09%6.21M4.34%-29.66M
-Change in receivables 56.61%-5.69M-10.26%-12.45M-104.54%-79K327.73%5.09M232.08%1.75M-62.73%-13.11M-29.64%-11.29M148.39%1.74M-138.33%-2.24M16.09%-1.33M
-Change in payables and accrued expense -80.78%1.71M181.78%12.98M-8.77%27.55M-1,266.07%-42.24M245.80%3.42M4,456.86%8.89M-835.02%-15.87M261.98%30.2M70.98%-3.09M-4,594.00%-2.35M
-Change in other current assets -14.67%-5.88M-7.88%-10.93M103.58%22.36M-76.91%-13.26M-367.70%-4.05M77.32%-5.13M43.79%-10.13M514.96%10.98M-1,115.45%-7.49M156.70%1.51M
-Change in other current liabilities 46.76%-7.95M82.52%-751K32.05%-1.48M55.81%-2.97M-57.98%-2.75M-186.26%-14.94M-1,584.71%-4.3M-177.02%-2.18M-3.90%-6.72M-31.77%-1.74M
-Change in other working capital -149.59%-8.81M-24.31%15.83M---------63.88%-42.21M501.76%17.76M17.65%20.92M---------1.48%-25.76M
Cash from discontinued investing activities
Operating cash flow 34.50%457.09M55.67%117.92M53.04%138.58M25.65%135.87M-1.06%64.74M39.96%339.86M-1.72%75.75M58.56%90.55M40.23%108.13M107.46%65.43M
Investing cash flow
Cash flow from continuing investing activities 90.67%-47.14M37.77%-8.44M11.54%-11.38M94.65%-11.18M94.02%-16.14M-997.05%-505.45M-20.29%-13.56M16.57%-12.87M-1,940.02%-209.08M-2,855.12%-269.95M
Net PPE purchase and sale 5.52%-1.97M0.61%-326K-166.67%-784K-4.32%-773K88.07%-86K-23.02%-2.08M41.43%-328K45.96%-294K-61.79%-741K-446.21%-721K
Net intangibles purchase and sale 90.70%-46.81M26.32%-9.75M15.70%-10.6M95.00%-10.41M94.04%-16.06M-1,034.23%-503.37M-23.52%-13.23M15.49%-12.57M-2,027.88%-208.34M-2,890.44%-269.23M
Net investment purchase and sale --1.64M------------------0----------------
Cash from discontinued investing activities
Investing cash flow 90.67%-47.14M37.77%-8.44M11.54%-11.38M94.65%-11.18M94.02%-16.14M-997.05%-505.45M-20.29%-13.56M16.57%-12.87M-1,940.02%-209.08M-2,855.12%-269.95M
Financing cash flow
Cash flow from continuing financing activities -772.22%-386.98M-12.90%-99.81M-48.51%-122.4M-161.22%-108.12M-209.42%-56.65M222.38%57.57M-2,248.38%-88.41M-4,163.86%-82.42M8,295.68%176.62M201.46%51.77M
Net issuance payments of debt -157.14%-100M0.00%-25M0.00%-25M-128.57%-50M--0421.84%175M---25M---25M--175M191.95%50M
Net common stock issuance -146.31%-299.25M-28.64%-81.02M-57.95%-92.42M---66.75M---59.07M---121.49M---62.98M---58.51M--0--0
Proceeds from stock option exercised by employees 21.04%11.41M36.08%5.96M-702.05%-5M399.26%9.48M-58.35%965K45.70%9.43M42.88%4.38M-59.51%830K333.56%1.9M152.95%2.32M
Net other financing activities 116.15%867K105.12%246K-90.67%25K-203.19%-855K365.75%1.45M-720.58%-5.37M-558.78%-4.81M1,318.18%268K89.12%-282K-122.45%-546K
Cash from discontinued financing activities
Financing cash flow -772.22%-386.98M-12.90%-99.81M-48.51%-122.4M-161.22%-108.12M-209.42%-56.65M222.38%57.57M-2,248.38%-88.41M-4,163.86%-82.42M8,295.68%176.62M201.46%51.77M
Net cash flow
Beginning cash position -26.74%295.95M-4.01%309.26M-6.86%304.46M14.59%287.89M-26.74%295.95M58.88%403.98M-3.56%322.16M12.59%326.89M11.34%251.23M58.88%403.98M
Current changes in cash 121.27%22.98M136.88%9.67M201.44%4.8M-78.10%16.57M94.73%-8.05M-172.16%-108.03M-137.49%-26.22M-110.82%-4.73M16.94%75.66M-433.64%-152.75M
End cash Position 7.76%318.93M7.76%318.93M-4.01%309.26M-6.86%304.46M14.59%287.89M-26.74%295.95M-26.74%295.95M-3.56%322.16M12.59%326.89M11.34%251.23M
Free cash flow 346.57%408.32M73.40%107.84M63.73%127.19M223.51%124.69M123.76%48.6M-184.17%-165.6M-5.49%62.19M86.35%77.69M-251.00%-100.95M-1,012.92%-204.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More